Department of Pediatrics, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03753, USA.
Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F456-62. doi: 10.1136/fetalneonatal-2011-301373. Epub 2012 May 6.
Neonatal sepsis due to intestinal bacterial translocation is a major cause of morbidity and mortality. Understanding microbial colonisation of the gut in prematurity may predict risk of sepsis to guide future strategies to manipulate the microbiome.
Prospective longitudinal study of premature infants. Stool samples were obtained weekly. DNA was extracted and the V6 hypervariable region of 16S rRNA was amplified followed by high throughput pyrosequencing, comparing subjects with and without sepsis.
Six neonates were 24-27 weeks gestation at birth and had 18 samples analysed. Two subjects had no sepsis during the study period, two developed late-onset culture-positive sepsis and two had culture-negative systemic inflammation. 324 350 sequences were obtained. The meconium was not sterile and had predominance of Lactobacillus, Staphylococcus and Enterobacteriales. Overall, infants who developed sepsis began life with low microbial diversity, and acquired a predominance of Staphylococcus, while healthy infants had more diversity and predominance of Clostridium, Klebsiella and Veillonella.
In very low birth weight infants, the authors found that meconium is not sterile and is less diverse from birth in infants who will develop late-onset sepsis. Empiric, prolonged antibiotics profoundly decrease microbial diversity and promote a microbiota that is associated not only with neonatal sepsis, but the predominant pathogen previously identified in the microbiome. Our data suggest that there may be a 'healthy microbiome' present in extremely premature neonates that may ameliorate risk of sepsis. More research is needed to determine whether altered antibiotics, probiotics or other novel therapies can re-establish a healthy microbiome in neonates.
由于肠道细菌易位导致的新生儿败血症是发病率和死亡率的主要原因。了解早产儿肠道微生物定植情况可预测败血症的风险,从而为未来的微生物组操作策略提供指导。
前瞻性纵向研究早产儿。每周采集粪便样本。提取 DNA,扩增 16S rRNA V6 高变区,进行高通量焦磷酸测序,比较有和无败血症的患者。
6 名婴儿出生时胎龄为 24-27 周,分析了 18 个样本。2 名患者在研究期间无败血症,2 名发生晚发性培养阳性败血症,2 名发生培养阴性全身炎症。共获得 324350 个序列。胎便并非无菌,以乳杆菌属、葡萄球菌属和肠杆菌目为主。总体而言,发生败血症的婴儿从出生开始就具有较低的微生物多样性,且以葡萄球菌属为主,而健康婴儿的多样性更高,以梭菌属、克雷伯菌属和韦荣球菌属为主。
在极低出生体重儿中,作者发现胎便并非无菌,而且在会发生晚发性败血症的婴儿中,从出生开始就具有较低的多样性。经验性、长期使用抗生素会显著降低微生物多样性,并促进一种与新生儿败血症相关的微生物群,这与先前在微生物组中发现的主要病原体有关。我们的数据表明,极早产儿可能存在“健康微生物组”,可降低败血症的风险。需要进一步研究确定是否可以通过改变抗生素、益生菌或其他新疗法来恢复新生儿的健康微生物组。